No abstract available
MeSH terms
-
Clinical Protocols*
-
Clinical Trials, Phase I as Topic / methods*
-
Drug Combinations
-
Gene Expression
-
Genetic Therapy*
-
Interleukin-2 / administration & dosage
-
Interleukin-2 / genetics
-
Interleukin-2 / therapeutic use*
-
Melanoma / immunology
-
Melanoma / pathology
-
Melanoma / therapy*
-
Neoplasm Metastasis
-
Plasmids
-
Superantigens / administration & dosage
-
Superantigens / genetics
-
Superantigens / therapeutic use
-
Vaccines, DNA / therapeutic use*
Substances
-
Drug Combinations
-
Interleukin-2
-
Superantigens
-
Vaccines, DNA